Advertisement

A Terrifying New Variant Could Elude Vaccines — BioNTech Won't Know For Two Weeks

A Terrifying New Variant Could Elude Vaccines — BioNTech Won't Know For Two Weeks

Vaccine stocks Pfizer, BioNTech and Moderna popped Friday as scientists grappled with a new Covid variant first detected in South Africa.